More Drugmakers Hike US Prices as New Year Begins

More Drugmakers Hike US Prices as New Year Begins
A shelf of drugs at a pharmacy in Quebec City. Jacques Boissinot/The Canadian Press-File
|Updated:

NEW YORK—Drugmakers including Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked United States list prices on more than 50 drugs on Wednesday. That brings the total New Year’s Day drug price increases to more than 250, according to data analyzed by healthcare research firm 3 Axis Advisors.

Reuters reported on Tuesday that drugmakers, including Pfizer Inc, GlaxoSmithKline PLC, and Sanofi SA were planning to increase prices on more than 200 drugs in the United States on Jan. 1.